STRATA Skin Sciences, Inc.

NasdaqCM SSKN

STRATA Skin Sciences, Inc. Market Capitalization on January 14, 2025: USD 12.30 M

STRATA Skin Sciences, Inc. Market Capitalization is USD 12.30 M on January 14, 2025, a -37.09% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • STRATA Skin Sciences, Inc. 52-week high Market Capitalization is USD 20.24 M on April 24, 2024, which is 64.53% above the current Market Capitalization.
  • STRATA Skin Sciences, Inc. 52-week low Market Capitalization is USD 9.18 M on August 16, 2024, which is -25.38% below the current Market Capitalization.
  • STRATA Skin Sciences, Inc. average Market Capitalization for the last 52 weeks is USD 13.78 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqCM: SSKN

STRATA Skin Sciences, Inc.

CEO Dr. Dolev Rafaeli Ph.D.
IPO Date Nov. 3, 2005
Location United States
Headquarters 5 Walnut Grove Drive
Employees 99
Sector Consumer Discretionary
Industries
Description

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Similar companies

NVNO

enVVeno Medical Corporation

USD 3.14

-1.57%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

AXGN

AxoGen, Inc.

USD 18.24

-0.06%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

AORT

Artivion, Inc.

USD 29.68

1.16%

CVRX

CVRx, Inc.

USD 16.15

7.38%

NXL

Nexalin Technology, Inc.

USD 2.78

10.76%

ELMD

Electromed, Inc.

USD 31.05

1.90%

LNSR

LENSAR, Inc.

USD 7.66

-4.96%

StockViz Staff

January 15, 2025

Any question? Send us an email